Claims for Patent: 10,081,699
✉ Email this page to a colleague
Summary for Patent: 10,081,699
| Title: | Rubber composition for tire tread, and pneumatic tire |
| Abstract: | A rubber composition contains a diene rubber component containing at least 20 mass % of a modified conjugated diene rubber, a silica, and a silane coupling agent; the modified conjugated diene rubber having at least one modified part and at least one conjugated diene rubber part; the conjugated diene rubber part having a conjugated diene copolymer block and an isoprene block containing from 70 mass % to 100 mass % of isoprene units in each conjugated diene rubber part; the modified part bonding to an end of the conjugated diene rubber part and having a functional group which interacts with the silica; a content of the silica being from 60 to 200 parts by mass per 100 parts by mass of the diene rubber component; the silane coupling agent being a polysiloxane represented by formula (1), (A)a(B)b(C)c(D)d(R1)eSiO(4-2a-b-c-d-e)/2, and having a content from 1.0 to 20 mass % of the content of the silica. |
| Inventor(s): | Masaki Sato, Satoshi Mihara |
| Assignee: | Yokohama Rubber Co Ltd |
| Application Number: | US14/770,457 |
Details for Patent 10,081,699
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | ARZERRA | ofatumumab | Injection | 125326 | October 26, 2009 | ⤷ Get Started Free | 2034-02-25 |
| Novartis Pharmaceuticals Corporation | ARZERRA | ofatumumab | Injection | 125326 | April 01, 2011 | ⤷ Get Started Free | 2034-02-25 |
| Novartis Pharmaceuticals Corporation | KESIMPTA | ofatumumab | Injection | 125326 | August 20, 2020 | ⤷ Get Started Free | 2034-02-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,081,699
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014129665 | ⤷ Get Started Free |
| United States of America | 2016009846 | ⤷ Get Started Free |
| South Korea | 20150110668 | ⤷ Get Started Free |
| South Korea | 101625019 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
